These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35484726)

  • 21. Potent Dual Polymerase/Exonuclease Inhibitory Activities of Antioxidant Aminothiadiazoles Against the COVID-19 Omicron Virus: A Promising In Silico/In Vitro Repositioning Research Study.
    Rabie AM; Eltayb WA
    Mol Biotechnol; 2024 Apr; 66(4):592-611. PubMed ID: 36690820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro.
    Hahn F; Wangen C; Häge S; Peter AS; Dobler G; Hurst B; Julander J; Fuchs J; Ruzsics Z; Überla K; Jäck HM; Ptak R; Muehler A; Gröppel M; Vitt D; Peelen E; Kohlhof H; Marschall M
    Viruses; 2020 Dec; 12(12):. PubMed ID: 33291455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uncovering Flexible Active Site Conformations of SARS-CoV-2 3CL Proteases through Protease Pharmacophore Clusters and COVID-19 Drug Repurposing.
    Pathak N; Chen YT; Hsu YC; Hsu NY; Kuo CJ; Tsai HP; Kang JJ; Huang CH; Chang SY; Chang YH; Liang PH; Yang JM
    ACS Nano; 2021 Jan; 15(1):857-872. PubMed ID: 33373194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening of Natural Products Inhibitors of SARS-CoV-2 Entry.
    González-Maldonado P; Alvarenga N; Burgos-Edwards A; Flores-Giubi ME; Barúa JE; Romero-Rodríguez MC; Soto-Rifo R; Valiente-Echeverría F; Langjahr P; Cantero-González G; Sotelo PH
    Molecules; 2022 Mar; 27(5):. PubMed ID: 35268843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current Landscape of Natural Products against Coronaviruses: Perspectives in COVID-19 Treatment and Anti-viral Mechanism.
    Shawon J; Akter Z; Hossen MM; Akter Y; Sayeed A; Junaid M; Afrose SS; Khan MA
    Curr Pharm Des; 2020; 26(41):5241-5260. PubMed ID: 33155902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Computational screening for potential drug candidates against the SARS-CoV-2 main protease.
    Silva Andrade B; Ghosh P; Barh D; Tiwari S; José Santana Silva R; Rodrigues de Assis Soares W; Silva Melo T; Santos Freitas A; González-Grande P; Sousa Palmeira L; Carlos Junior Alcantara L; Giovanetti M; Góes-Neto A; Ariston de Carvalho Azevedo V
    F1000Res; 2020; 9():. PubMed ID: 33447372
    [No Abstract]   [Full Text] [Related]  

  • 27. Enhanced Remdesivir Analogues to Target SARS-CoV-2.
    Majima R; Edwards TC; Dreis CD; Geraghty RJ; Bonnac LF
    Molecules; 2023 Mar; 28(6):. PubMed ID: 36985586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiviral plant-derived natural products to combat RNA viruses: Targets throughout the viral life cycle.
    Owen L; Laird K; Shivkumar M
    Lett Appl Microbiol; 2022 Sep; 75(3):476-499. PubMed ID: 34953146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In-Silico targeting of SARS-CoV-2 NSP6 for drug and natural products repurposing.
    Abdelkader A; Elzemrany AA; El-Nadi M; Elsabbagh SA; Shehata MA; Eldehna WM; El-Hadidi M; Ibrahim TM
    Virology; 2022 Aug; 573():96-110. PubMed ID: 35738174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishing an Analogue Based In Silico Pipeline in the Pursuit of Novel Inhibitory Scaffolds against the SARS Coronavirus 2 Papain-Like Protease.
    Hajbabaie R; Harper MT; Rahman T
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33672721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In silico evaluation of Philippine Natural Products against SARS-CoV-2 Main Protease.
    Cheng AJT; Macalino SJY; Billones JB; Balolong MP; Murao LAE; Carrillo MCO
    J Mol Model; 2022 Oct; 28(11):345. PubMed ID: 36205801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiviral fungal metabolites and some insights into their contribution to the current COVID-19 pandemic.
    Takahashi JA; Barbosa BVR; Lima MTNS; Cardoso PG; Contigli C; Pimenta LPS
    Bioorg Med Chem; 2021 Sep; 46():116366. PubMed ID: 34438338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potent Anti-SARS-CoV-2 Activity by the Natural Product Gallinamide A and Analogues via Inhibition of Cathepsin L.
    Ashhurst AS; Tang AH; Fajtová P; Yoon MC; Aggarwal A; Bedding MJ; Stoye A; Beretta L; Pwee D; Drelich A; Skinner D; Li L; Meek TD; McKerrow JH; Hook V; Tseng CT; Larance M; Turville S; Gerwick WH; O'Donoghue AJ; Payne RJ
    J Med Chem; 2022 Feb; 65(4):2956-2970. PubMed ID: 34730959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of lead natural products for developing pan-SARS-CoV-2 therapeutics.
    Pérez-Vargas J; Shapira T; Olmstead AD; Villanueva I; Thompson CAH; Ennis S; Gao G; De Guzman J; Williams DE; Wang M; Chin A; Bautista-Sánchez D; Agafitei O; Levett P; Xie X; Nuzzo G; Freire VF; Quintana-Bulla JI; Bernardi DI; Gubiani JR; Suthiphasilp V; Raksat A; Meesakul P; Polbuppha I; Cheenpracha S; Jaidee W; Kanokmedhakul K; Yenjai C; Chaiyosang B; Teles HL; Manzo E; Fontana A; Leduc R; Boudreault PL; Berlinck RGS; Laphookhieo S; Kanokmedhakul S; Tietjen I; Cherkasov A; Krajden M; Nabi IR; Niikura M; Shi PY; Andersen RJ; Jean F
    Antiviral Res; 2023 Jan; 209():105484. PubMed ID: 36503013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular Simulation-Based Investigation of Highly Potent Natural Products to Abrogate Formation of the nsp10-nsp16 Complex of SARS-CoV-2.
    Mohammad A; Alshawaf E; Marafie SK; Abu-Farha M; Al-Mulla F; Abubaker J
    Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33919870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cheminformatics-Based Identification of Potential Novel Anti-SARS-CoV-2 Natural Compounds of African Origin.
    Kwofie SK; Broni E; Asiedu SO; Kwarko GB; Dankwa B; Enninful KS; Tiburu EK; Wilson MD
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33466743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring the magic bullets to identify Achilles' heel in SARS-CoV-2: Delving deeper into the sea of possible therapeutic options in Covid-19 disease: An update.
    Thakur S; Mayank ; Sarkar B; Ansari AJ; Khandelwal A; Arya A; Poduri R; Joshi G
    Food Chem Toxicol; 2021 Jan; 147():111887. PubMed ID: 33253764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phylogenetic Analysis and Structural Perspectives of RNA-Dependent RNA-Polymerase Inhibition from SARs-CoV-2 with Natural Products.
    Khan A; Khan M; Saleem S; Babar Z; Ali A; Khan AA; Sardar Z; Hamayun F; Ali SS; Wei DQ
    Interdiscip Sci; 2020 Sep; 12(3):335-348. PubMed ID: 32617855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural products and phytochemicals as potential anti-SARS-CoV-2 drugs.
    Merarchi M; Dudha N; Das BC; Garg M
    Phytother Res; 2021 Oct; 35(10):5384-5396. PubMed ID: 34132421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of natural compounds as SARS-CoV-2 entry inhibitors by molecular docking-based virtual screening with bio-layer interferometry.
    Zhang D; Hamdoun S; Chen R; Yang L; Ip CK; Qu Y; Li R; Jiang H; Yang Z; Chung SK; Liu L; Wong VKW
    Pharmacol Res; 2021 Oct; 172():105820. PubMed ID: 34403732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.